{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05029960",
            "orgStudyIdInfo": {
                "id": "UBRT21074"
            },
            "organization": {
                "fullName": "University of Rochester",
                "class": "OTHER"
            },
            "briefTitle": "Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas",
            "officialTitle": "Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "tolerability-and-activity-of-brivaracetam-brv-in-patients-with-diffuse-gliomas"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-05-17",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-08-25",
            "studyFirstSubmitQcDate": "2021-08-25",
            "studyFirstPostDateStruct": {
                "date": "2021-09-01",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-05",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Thomas Wychowski",
                "investigatorTitle": "Associate Professor - Department of Neurology , Epilepsy (SMD)",
                "investigatorAffiliation": "University of Rochester"
            },
            "leadSponsor": {
                "name": "University of Rochester",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": true
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this study is to determine whether the study medication, brivaracetam, is tolerable and safe for patients with brain tumors.",
            "detailedDescription": "In this study, subjects will receive usual treatment for their brain tumor. In addition, they will be given brivaracetam at a dose of 50 mg twice daily."
        },
        "conditionsModule": {
            "conditions": [
                "Brain Tumor"
            ],
            "keywords": [
                "Brain Tumor",
                "Brivaracetam",
                "Epilepsy"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Experimental",
                    "type": "EXPERIMENTAL",
                    "description": "Brivaracetam at a dose of 50 mg twice daily for 6 months",
                    "interventionNames": [
                        "Drug: Brivaracetam"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Brivaracetam",
                    "description": "Dose of 50 mg twice daily for 6 months",
                    "armGroupLabels": [
                        "Experimental"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety of Brivaracetam",
                    "description": "Evaluate adverse events",
                    "timeFrame": "6 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Voluntariness for study participation",
                    "description": "Number of people that declined to participate",
                    "timeFrame": "6 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years with pathologic diagnosis of a supratentorial diffuse astrocytic or oligodendroglial tumor\n* Patients must be able to provide informed consent\n\nExclusion Criteria:\n\n* A pre-existing seizure disorder or epilepsy syndrome prior to tumor diagnosis\n* Active maintenance therapy with an antiepileptic seizure drug (AED) prior to diagnosis of tumor\n* Patients who have experienced an epileptic seizure as the presenting symptom of their brain tumor\n* Predicted life expectancy of less than 6 months from the time of screening\n* Pregnancy\n* Patients with clinically significant hepatic disease (elevated aminotransferases \\[bilirubin, alkaline phosphatase\\] \\> 3 times upper limit normal)\n* Patients with stage 4 or greater renal disease (GFR \\<30 mL/min/1.73 m2)\n* Patients who are unable to swallow a tablet\n* Patients with active suicidal ideation or a history of suicide attempt or other serious psychiatric disorder having required hospitalization within the previous 2 years.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Thomas Wychowski",
                    "role": "CONTACT",
                    "phone": "585-275-4401",
                    "email": "Thomas_Wychowski@URMC.Rochester.edu"
                }
            ],
            "locations": [
                {
                    "facility": "University of Rochester Medical Center",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "New York",
                    "zip": "14642",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Principal Investigator",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 43.15478,
                        "lon": -77.61556
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001932",
                    "term": "Brain Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000016543",
                    "term": "Central Nervous System Neoplasms"
                },
                {
                    "id": "D000009423",
                    "term": "Nervous System Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000001927",
                    "term": "Brain Diseases"
                },
                {
                    "id": "D000002493",
                    "term": "Central Nervous System Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9020",
                    "name": "Glioma",
                    "relevance": "LOW"
                },
                {
                    "id": "M7983",
                    "name": "Epilepsy",
                    "relevance": "LOW"
                },
                {
                    "id": "M5209",
                    "name": "Brain Neoplasms",
                    "asFound": "Brain Tumor",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18937",
                    "name": "Central Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M12367",
                    "name": "Nervous System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M5204",
                    "name": "Brain Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5742",
                    "name": "Central Nervous System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2519",
                    "name": "Glioma",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000482793",
                    "term": "Brivaracetam"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000927",
                    "term": "Anticonvulsants"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M249745",
                    "name": "Brivaracetam",
                    "asFound": "/mm",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4246",
                    "name": "Anticonvulsants",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "AntiConv",
                    "name": "Anticonvulsants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}